Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1609–1632 of 3,077 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intracranial Vascular Disorders Clear all

Conditions: Fabry Disease
Interventions: Agalsidase beta; Biological
Lead sponsor: Genzyme, a Sanofi Company; Industry
Eligibility: Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 6
States / cities: Coral Springs, Florida • Decatur, Georgia • Baltimore, Maryland + 3 more

Conditions: Arterial Ischemic Stroke (AIS) in Children
Interventions: Autologous Human Cord Blood derived Stem Cell injection; Biological
Lead sponsor: Aryn Knight; Other
Eligibility: 6 Weeks to 6 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stroke, Cognitive Change, Neurological Injury, Cognitive Impairment, Activity, Motor
Interventions: Ageless Grace; Behavioral
Lead sponsor: Saint Joseph's University, Philadelphia; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Ischemic Stroke, Patent Foramen Ovale
Interventions: Warfarin, Aspirin; Drug
Lead sponsor: Columbia University; Other
Eligibility: 30 Years to 85 Years
Enrollment: 630 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2000
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 65 Years to 90 Years · Female only
Enrollment: 1,426 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Carotid Stenosis, Mild Cognitive Impairment, Periodontitis
Interventions: Standard Treatment, Intensive Treatment; Procedure
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 60 Years to 100 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: GERD
Interventions: PEGJ tube; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Fabry Disease
Interventions: AT1001 150 mg; Drug
Lead sponsor: Amicus Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 4
States / cities: Costa Mesa, California • Miami, Florida • Orlando, Florida

Conditions: Subarachnoid Hemorrhage, Cerebral Vasospasm
Interventions: Dantrolene, Placebo; Drug
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Intracranial Aneurysm, Ruptured Aneurysm
Interventions: Pipeline™ Flex Embolization Device with Shield Technology™; Device
Lead sponsor: Medtronic Neurovascular Clinical Affairs; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 7
States / cities: New Haven, Connecticut • Marietta, Georgia • Chicago, Illinois + 4 more

Conditions: Amyotrophic Lateral Sclerosis, Stroke
Interventions: Use of BCI; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 16 Years to 100 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Subarachnoid Hemorrhage (SAH)
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Intracranial Aneurysms, Peripheral Aneurysms
Interventions: PC 400 coils (Penumbra ); Device
Lead sponsor: Penumbra Inc.; Industry
Eligibility: Not listed
Enrollment: 517 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 6
States / cities: Newport Beach, California • Chicago, Illinois • New York, New York + 3 more

Conditions: Atrial Fibrillation
Interventions: Apixaban, Vitamin K antagonist; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 18,591 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke
Interventions: augmented reality; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 2
States / cities: Boston, Massachusetts • Pittsburgh, Pennsylvania

Conditions: Stroke
Interventions: LAAx TigerPaw System; Device
Lead sponsor: LAAx, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Acute Stroke
Interventions: Robot-assisted therapy, Traditional therapy; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2003
U.S. locations: 1
States / cities: Temple, Texas

Conditions: Hypoxic-Ischemic Encephalopathy
Interventions: Optical Coherence Tomography; Device
Lead sponsor: Duke University; Other
Eligibility: Up to 20 Days
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: Durham, North Carolina • Salt Lake City, Utah

Conditions: Type 2 Diabetes
Interventions: Tirzepatide, Dulaglutide, Semaglutide; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 40 Years and older
Enrollment: 70,000 participants
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke
Interventions: Modified cognitive behavioral therapy plus problem-solving, usual care; Behavioral · Other
Lead sponsor: University of Washington; Other
Eligibility: 21 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Stroke, Stroke Sequelae, Stroke/Brain Attack
Interventions: Magnetoencephalography (MEG); Diagnostic Test
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 55 participants
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Atrial Fibrillation, Stroke, Bleeding
Interventions: WATCHMAN FLX LAAC Device, Non-Vitamin K Oral Anticoagulant; Device · Drug
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 95
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 83 more

Conditions: Stenoses, Carotid Artery
Interventions: Carotid endarterectomy with routine shount, Carotid endarterectomy with selective shunt; Procedure
Lead sponsor: CAMC Health System; Other
Eligibility: 18 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Brain Infarction, Brain Ischemia
Interventions: t DC stimulation, tDCStimulation; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 19 Years to 90 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Search by objective public record fields.

A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta

Umbilical Cord Blood in the Treatment of Stroke in Children.

Influence of Cognition on Activity and Participation in People With Stroke

Patent Foramen Ovale in Cryptogenic Stroke Study

Evaluating the Effects of Hormone Replacement Therapy on Brain Function (The WHIMS-MRI Study)

Dental Carotid Cognitive Study

Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J)

Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function

Safety Study of Dantrolene in Subarachnoid Hemorrhage

EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms With the Pipeline™ Flex Embolization Device With Shield TEchnology™ (ELEVATE)

Telehealth Implementation of Brain-Computer Interface

Serum Procalcitonin

Study of the Penumbra Coil 400 System to Treat Aneurysm

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation

Exclusion of the Left Atrial Appendage (LAA) With the LAAx, Inc. TigerPaw System

Robot Assisted Upper Limb Neuro-Rehabilitation

Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants

Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

Psychosocial/Behavioral Intervention in Post-Stroke Depression

Imaging Post-Stroke Recovery: Using MEG to Evaluate Cognition

CHAMPION-AF Clinical Trial

Selective Versus Routine Shunting in Carotid Endarterectomy Patients

Transcranial Direct Current Stimulation, Improve Functional Motor Recovery, Affected Arm